tiprankstipranks
Dr. Reddy's Laboratories Ltd (RDY)
NYSE:RDY
Holding RDY?
Track your performance easily

Dr Reddy's Laboratories (RDY) Financial Statements

396 Followers

Dr Reddy's Laboratories Financial Overview

Dr Reddy's Laboratories's market cap is currently ―. The company's EPS TTM is $0.767; its P/E ratio is 18.69; and it has a dividend yield of 0.57%. Dr Reddy's Laboratories is scheduled to report earnings on January 29, 2025, and the estimated EPS forecast is $0.21. See an overview of income statement, balance sheet, and cash flow financials.
Mar 24Mar 23Dec 22Sep 22Jun 22
Income Statement-
Total Revenue--₹ 67.70B₹ 63.06B₹ 52.15B
Gross Profit--₹ 40.09B₹ 37.25B₹ 26.01B
EBIT--₹ 16.77B₹ 16.42B₹ 15.00B
EBITDA--₹ 16.77B₹ 19.55B₹ 18.05B
Net Income Common Stockholders--₹ 12.47B₹ 11.13B₹ 11.88B
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments₹ 81.47B₹ 66.50B₹ 50.16B₹ 27.57B₹ 34.34B
Total Assets₹ 387.52B₹ 321.85B-₹ 290.97B₹ 295.98B
Total Debt₹ 20.02B₹ 6.08B₹ 0.00₹ 17.29B₹ 24.67B
Net Debt₹ -61.45B₹ -60.42B₹ -50.16B₹ -10.29B₹ -9.68B
Total Liabilities₹ 106.97B₹ 95.13B-₹ 84.75B₹ 95.59B
Stockholders Equity₹ 280.55B₹ 226.72B₹ 220.27B₹ 206.22B₹ 200.39B
Cash Flow-
Free Cash Flow--₹ 20.16B₹ 5.95B₹ -2.04B
Operating Cash Flow--₹ 23.26B₹ 9.28B₹ 6.66B
Investing Cash Flow--₹ -26.41B₹ 5.73B₹ -4.92B
Financing Cash Flow--₹ 583.00M₹ -12.35B₹ -10.80B
Currency in INR

Dr Reddy's Laboratories Earnings and Revenue History

Dr Reddy's Laboratories Debt to Assets

Dr Reddy's Laboratories Cash Flow

Dr Reddy's Laboratories Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis